BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8619939)

  • 1. High dose rate intracavitary brachytherapy in the treatment of nasopharyngeal carcinoma.
    Leung TW; Tung SY; Wong VY; Lui CM; Sze WK; Cheung KL; Lau WH; O SK
    Acta Oncol; 1996; 35(1):43-7. PubMed ID: 8619939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients.
    Teo PM; Kwan WH; Yu P; Lee WY; Leung SF; Choi P
    Clin Oncol (R Coll Radiol); 1996; 8(3):160-6. PubMed ID: 8814370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].
    Lin SJ; Pan JJ; Wu JX; Han L; Pan CZ
    Ai Zheng; 2007 Feb; 26(2):208-11. PubMed ID: 17298755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined teletherapy and intracavitary brachytherapy boost for the treatment of nasopharyngeal carcinoma.
    Kouvaris J; Plataniotis GA; Sandilos P; Dardoufas C; Damatopoulou A; Vlahos L; Papavasiliou C
    Radiother Oncol; 1996 Mar; 38(3):263-7. PubMed ID: 8693109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
    Leung TW; Wong VY; Sze WK; Lui CM; Tung SY
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
    Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK
    Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-irradiation for locally recurrent nasopharyngeal carcinoma.
    McLean M; Chow E; O'Sullivan B; Munro A; Leung PM; Loblaw DA; Panzarella T
    Radiother Oncol; 1998 Aug; 48(2):209-11. PubMed ID: 9783894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of brachytherapy in early-stage nasopharyngeal carcinoma.
    Chang JT; See LC; Tang SG; Lee SP; Wang CC; Hong JH
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1019-24. PubMed ID: 8985022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
    Hwang JM; Fu KK; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
    Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-treatment of nasopharyngeal carcinoma in 53 patients.
    Pryzant RM; Wendt CD; Delclos L; Peters LJ
    Int J Radiat Oncol Biol Phys; 1992; 22(5):941-7. PubMed ID: 1555986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of interstitial brachytherapy via parapharynx involvement transnasal approach to enhance dose in radiotherapy for nasopharyngeal carcinoma].
    Chen MY; Cao XP; Sun R; Hua YJ; Li AJ; Liu YY; Ouyang Y; Guo L; Chen QY; Hong MH
    Ai Zheng; 2007 May; 26(5):513-8. PubMed ID: 17672943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary experience in HDR brachytherapy for 72 nasopharyngeal carcinoma patients.
    Gao L; Xu GZ; Yin WB; Yan JH; Cai WM; Gu XZ
    Chin Med J (Engl); 1993 Jun; 106(6):467-70. PubMed ID: 8222900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early stage nasopharyngeal carcinoma: radiotherapy dose and time factors in tumor control.
    Chang JT; See LC; Liao CT; Chen LH; Leung WM; Chen SW; Chen WC
    Jpn J Clin Oncol; 1998 Mar; 28(3):207-13. PubMed ID: 9614445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma.
    Zheng XK; Chen LH; Chen YQ; Deng XG
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):165-70. PubMed ID: 15337552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.
    Gupta AK; Vicini FA; Frazier AJ; Barth-Jones DC; Edmundson GK; Mele E; Gustafson GS; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1055-60. PubMed ID: 10192355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved local control for early T-stage nasopharyngeal carcinoma--a tale of two hospitals.
    Teo PM; Leung SF; Fowler J; Leung TW; Tung Y; O SK; Lee WY; Zee B
    Radiother Oncol; 2000 Nov; 57(2):155-66. PubMed ID: 11054519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.